查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1559024

结核病诊断市场：2024-2031年全球产业分析、规模、占有率、成长、趋势、预测

Tuberculosis Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 177 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球结核病诊断市场的综合报告，深入分析了关键市场动态，包括市场驱动因素、趋势、机会和挑战。这份详细的报告揭示了预测期内的市场结构和成长潜力。

主要见解

  • 结核病诊断市场规模（2024年）：23亿美元
  • 预测市场规模（2031年）：33亿美元
  • 全球市场成长率（2024-2031年年复合成长率）：5.5%

结核病诊断市场-调查范围：

结核病诊断包括目的是检测和诊断结核病（世界上最致命的传染病之一）的各种测试和工具。这些诊断在识别活动性和潜伏性结核病感染、指导治疗和监测结核病传播方面发挥重要作用。该市场的推动因素包括结核病患者的不断上升、诊断技术的进步以及对早期诊断和治疗的认识不断增强。

市场驱动因素：

有几个关键因素推动全球结核病诊断市场的成长。许多地区、特别是发展中国家的结核病发生率上升是一个重要的驱动因素。政府消除结核病的努力，加上世界卫生组织（WHO）等全球卫生组织的资助，推动对有效诊断解决方案的需求。分子诊断和即时检测等技术进步也透过实现更快、更准确的疾病检测来推动市场成长。对早期检测以防止结核病传播的日益重视也推动了先进诊断工具的采用。

市场限制因素：

儘管存在成长潜力，结核病诊断市场仍面临一定的挑战。关键的抑制因素之一是先进诊断技术的高成本，这在结核病最受欢迎的低收入和中等收入国家可能令人望而却步。此外，农村和未开发地区医疗设施和诊断基础设施不足也是市场成长的障碍。结核病诊断的复杂性以及需要训练有素的卫生专业人员进行测试和解释结果进一步限制了其在资源匮乏地区的采用。

市场机会：

结核病诊断市场提供了巨大的成长机会，特别是由于诊断工具和技术的不断创新。开发具有成本效益、携带式且易于使用的诊断设备市场是在服务不足的地区扩大市场的重大机会。此外，日益采用数位健康解决方案和远距医疗来进行远距结核病诊断和监测也可以推动市场成长。诊断公司与医疗机构之间的策略联盟可望加强研发，进一步提高结核病诊断能力。

本报告涵盖的主要问题

  • 推动全球结核病诊断市场的关键因素是什么？
  • 哪些地区和卫生系统对结核病诊断工具的需求最高？
  • 技术创新如何影响结核病诊断市场状况？
  • 谁是结核病诊断市场竞争的主要参与者？
  • 全球结核病诊断市场的新趋势和未来成长前景是什么？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 课题
    • 主要趋势
  • 宏观经济因素
    • 全球 GDP 成长前景
    • 全球医疗支出展望
  • 新冠肺炎（COVID-19）影响分析
  • 预测因子 - 相关性和影响

第3章 附加价值见解

  • 产品采用率分析
  • 疾病流行病学
  • 监理状况
  • 价值链分析
  • 主要交易和合併
  • PESTLE分析
  • 波特五力分析

第4章 全球结核病诊断市场展望：实绩（2019-2023年）与预测（2024-2031年）

  • 全球结核病诊断市场展望：检验类型
    • 简介/主要调查结果
    • 2019-2023年历史市场规模（十亿美元）分析，依检验类型
    • 2024-2031年目前市场规模（十亿美元）的分析与预测，依检验类型
      • 核酸检测
      • SMEAR显微镜检查
      • 辐射测试
  • 市场吸引力分析：考试类型
  • 全球结核病诊断市场前景：最终用户
    • 简介/主要调查结果
    • 2019-2023年历史市场规模（十亿美元）分析，依最终用户
    • 2024-2031目前市场规模（十亿美元）的分析与预测，依最终用户
      • 医院/诊所
      • 诊断中心
  • 市场吸引力分析：最终用户

第5章 全球结核病诊断市场前景：地区

  • 2019-2023年过去市场规模（十亿美元）分析，依地区
  • 2024-2031年当前市场规模（十亿美元）分析和预测，依地区
    • 北美
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东、非洲
  • 市场吸引力分析：地区

第6章 北美结核病诊断市场展望：实绩（2019-2023年）与预测（2024-2031年）

第7章 欧洲结核病诊断市场展望：实绩（2019-2023年）和预测（2024-2031年）

第8章 东亚结核病诊断市场展望：实绩（2019-2023年）与预测（2024-2031年）

第9章 南亚和大洋洲结核病诊断市场展望：实绩（2019-2023年）和预测（2024-2031年）

第10章 拉丁美洲结核病诊断市场展望：实绩（2019-2023年）和预测（2024-2031年）

第11章 中东和非洲结核病诊断市场展望：实绩（2019-2023年）和预测（2024-2031年）

第12章 竞争态势

  • 2023年市场占有率分析
  • 市场结构
    • 依市场划分的竞争强度图
    • 竞争仪表板
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Abbott
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • BD
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • Cepheid
    • DiaSorin SpA
    • Hain Lifescience GmbH
    • Oxford Immunotec
    • 其他

第13章 附录

  • 调查方法
  • 调查假设
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP34779

Persistence Market Research has recently released a comprehensive report on the global Tuberculosis Diagnostics Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.

Key Insights:

  • Tuberculosis Diagnostics Market Size (2024E): US$2.3 Bn
  • Projected Market Value (2031F): US$3.3 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 5.5%

Tuberculosis Diagnostics Market - Report Scope:

Tuberculosis diagnostics encompass a wide range of tests and tools designed to detect and diagnose tuberculosis (TB), one of the world's deadliest infectious diseases. These diagnostics play a crucial role in identifying active and latent TB infections, guiding treatment, and monitoring the spread of the disease. The market is driven by the increasing prevalence of TB, advancements in diagnostic technologies, and growing awareness about early diagnosis and treatment.

Market Growth Drivers:

Several key factors are fueling the growth of the global Tuberculosis Diagnostics Market. The rising incidence of TB in many regions, particularly in developing nations, is a significant driver. Government initiatives aimed at eliminating TB, coupled with funding from global health organizations like the World Health Organization (WHO), are boosting demand for effective diagnostic solutions. Technological advancements, such as molecular diagnostics and point-of-care testing, are also propelling market growth by enabling faster and more accurate detection of the disease. The increasing focus on early detection to prevent the spread of TB is further driving the adoption of advanced diagnostic tools.

Market Restraints:

Despite the growth potential, the Tuberculosis Diagnostics Market faces certain challenges. One of the primary restraints is the high cost of advanced diagnostic technologies, which can be prohibitive in low- and middle-income countries where TB is most prevalent. Additionally, the lack of access to healthcare facilities and diagnostic infrastructure in rural and underdeveloped regions poses a barrier to market growth. The complexity of TB diagnostics and the need for trained healthcare professionals to administer tests and interpret results can further limit adoption in resource-constrained settings.

Market Opportunities:

The Tuberculosis Diagnostics Market offers substantial growth opportunities, particularly with ongoing innovations in diagnostic tools and technologies. The development of cost-effective, portable, and user-friendly diagnostic devices presents a significant opportunity for market expansion in underserved regions. The increasing adoption of digital health solutions and telemedicine for remote TB diagnosis and monitoring can also drive market growth. Strategic collaborations between diagnostic companies and healthcare organizations are expected to enhance research and development, further advancing the capabilities of TB diagnostics.

Key Questions Answered in the Report:

  • What are the primary factors driving the global Tuberculosis Diagnostics Market?
  • Which regions and healthcare systems are experiencing the highest demand for TB diagnostic tools?
  • How are technological innovations influencing the market landscape for TB diagnostics?
  • Who are the leading players in the Tuberculosis Diagnostics Market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future growth prospects in the global TB diagnostics market?

Competitive Intelligence and Business Strategy:

Leading players in the Tuberculosis Diagnostics Market, including companies like Cepheid, BD (Becton, Dickinson and Company), and Abbott Laboratories, are focusing on innovation, research and development, and strategic collaborations to strengthen their market positions. These companies are investing in the development of advanced molecular diagnostic tools and rapid testing kits that provide faster and more accurate results. Partnerships with healthcare providers and governmental health agencies are key for market penetration and addressing the global TB burden. Additionally, these companies are striving to reduce the cost of diagnostics and improve accessibility in low-resource settings, which is crucial for long-term success in the Tuberculosis Diagnostics Market.

Key Companies Profiled:

  • Abbott
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • BD
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Cepheid
  • DiaSorin S.p.A.
  • Hain Lifescience GmbH
  • Oxford Immunotec

Market Segmentation

By Test Type

  • Nucleic Acid Testing
  • SMEAR Microscopy
  • Radiography Tests

By End User

  • Hospitals & Clinics
  • Diagnostics Centres

By Region

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • East Asia
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Tuberculosis Diagnostics Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Global Tuberculosis Diagnostics Market Outlook: Test Type
    • 4.1.1. Introduction / Key Findings
    • 4.1.2. Historical Market Size (US$ Bn) Analysis, By Test Type, 2019-2023
    • 4.1.3. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024-2031
      • 4.1.3.1. Nucleic Acid Testing
      • 4.1.3.2. SMEAR Microscopy
      • 4.1.3.3. Radiography Tests
  • 4.2. Market Attractiveness Analysis: Test Type
  • 4.3. Global Tuberculosis Diagnostics Market Outlook: End-user
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2023
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2024-2031
      • 4.3.3.1. Hospitals & Clinics
      • 4.3.3.2. Diagnostics Centres
  • 4.4. Market Attractiveness Analysis: End-user

5. Global Tuberculosis Diagnostics Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By End User
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 6.4.1. U.S.
    • 6.4.2. Canada
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 6.5.1. Nucleic Acid Testing
    • 6.5.2. SMEAR Microscopy
    • 6.5.3. Radiography Tests
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 6.6.1. Hospitals & Clinics
    • 6.6.2. Diagnostics Centres
  • 6.7. Market Attractiveness Analysis

7. Europe Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By End User
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. U.K.
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Russia
    • 7.4.7. Turkey
    • 7.4.8. Rest of Europe
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 7.5.1. Nucleic Acid Testing
    • 7.5.2. SMEAR Microscopy
    • 7.5.3. Radiography Tests
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 7.6.1. Hospitals & Clinics
    • 7.6.2. Diagnostics Centres
  • 7.7. Market Attractiveness Analysis

8. East Asia Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By End User
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. South Korea
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 8.5.1. Nucleic Acid Testing
    • 8.5.2. SMEAR Microscopy
    • 8.5.3. Radiography Tests
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 8.6.1. Hospitals & Clinics
    • 8.6.2. Diagnostics Centres
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By End User
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 9.4.1. India
    • 9.4.2. Southeast Asia
    • 9.4.3. ANZ
    • 9.4.4. Rest of South Asia & Oceania
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 9.5.1. Nucleic Acid Testing
    • 9.5.2. SMEAR Microscopy
    • 9.5.3. Radiography Tests
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 9.6.1. Hospitals & Clinics
    • 9.6.2. Diagnostics Centres
  • 9.7. Market Attractiveness Analysis

10. Latin America Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By End User
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 10.4.1. Brazil
    • 10.4.2. Mexico
    • 10.4.3. Rest of Latin America
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 10.5.1. Nucleic Acid Testing
    • 10.5.2. SMEAR Microscopy
    • 10.5.3. Radiography Tests
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 10.6.1. Hospitals & Clinics
    • 10.6.2. Diagnostics Centres
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By End User
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 11.4.1. GCC Countries
    • 11.4.2. Egypt
    • 11.4.3. South Africa
    • 11.4.4. Northern Africa
    • 11.4.5. Rest of Middle East & Africa
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 11.5.1. Nucleic Acid Testing
    • 11.5.2. SMEAR Microscopy
    • 11.5.3. Radiography Tests
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 11.6.1. Hospitals & Clinics
    • 11.6.2. Diagnostics Centres
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Abbott
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. QIAGEN
    • 12.3.3. Thermo Fisher Scientific Inc.
    • 12.3.4. BD
    • 12.3.5. F. Hoffmann-La Roche AG
    • 12.3.6. Hologic, Inc.
    • 12.3.7. Cepheid
    • 12.3.8. DiaSorin S.p.A.
    • 12.3.9. Hain Lifescience GmbH
    • 12.3.10. Oxford Immunotec
    • 12.3.11. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations